Every year, pneumococcal disease takes a heavy toll on human health. In 2019 alone, pneumonia claimed the lives of more than 740,000 children under the age of five. In the United States, pneumococcal pneumonia stands out as a leading bacterial cause of hospitalization, while pneumococcal meningitis is deadly for older adults, killing one in six who are infected.
These statistics highlight the profound impact pneumococcal disease can have on vulnerable populations. The pneumococcal vaccine is an effective preventive measure recommended by the Centers for Disease Control and Prevention (CDC) to safeguard your health and protect those around you who are at high risk.
[signup]
Understanding Pneumonia and Its Risks
Pneumonia is a type of lung infection that causes the lungs to swell and fill with fluid or pus. It commonly causes the following symptoms:
- Productive cough
- Chest pain
- Shortness of breath
- Fatigue
- Fever and chills
Pneumonia is categorized by the type of bug that causes the infection and how the infection is transmitted.
- Community-Acquired Pneumonia (CAP): CAP encompasses pneumonia transmitted outside a healthcare facility. Bacteria, viruses, and fungi can cause CAP. The most common cause of CAP is infection with Streptococcus pneumoniae, which infects over 900,000 Americans annually.
- Hospital-Acquired Pneumonia (HAP): HAP is a lung infection that develops in hospitalized patients. It can be more serious than CAP because antibiotic-resistant bacteria often cause it.
- Healthcare-Associated Pneumonia (HCAP): People living in a long-term or assisted living care facility can get HCAP. Like HAP, HCAP is often caused by antibiotic-resistant bacteria.
- Ventilator-Associated Pneumonia (VAP): VAP is a type of infection that develops in a person who has been on a ventilator for more than 48 hours. It is common in ICU patients.
- Aspiration Pneumonia: If food, saliva, or stomach contents are inhaled (aspirated) into the lungs, they can cause infection days to weeks later.
Who Is Most at Risk?
Risk factors for getting pneumonia include:
- Being younger than 5 or older than 65
- Having a lung or heart condition, including cystic fibrosis, asthma, COPD, or pulmonary fibrosis
- Having a neurological disease that makes it difficult to swallow, such as dementia, Parkinson's disease, or stroke
- Living in the hospital or at a long-term care facility
- Having a cochlear implant
- Smoking
- Pregnancy
- Having a weakened immune system
Pneumonia Vaccine Basics
The pneumococcal vaccine is designed to protect against pneumococcal diseases – those that are caused by Streptococcus pneumoniae. These include:
- Pneumonia
- Meningitis (infection of the membranes that cover the brain and spinal cord)
- Bacteremia (bloodstream infection)
- Otitis media (ear infection)
- Sinusitis (sinus infection)
According to the CDC, vaccination is the best way to prevent pneumococcal disease.
When you receive the vaccine, it introduces a small, harmless part of the Streptococcus pneumoniae bacteria into your body. This doesn't make you sick, but your body creates special cells and antibodies that remember the bacteria, so if you come into contact with it in the future, your immune system can quickly respond to stop the infection.
Types of Pneumonia Vaccines
There are two types of pneumococcal vaccines available in the United States:
Pneumococcal Polysaccharide Vaccine (PPSV23)
A polysaccharide vaccine is made from long chains of sugar molecules called polysaccharides, which look like the outer surface of certain types of pneumococcal bacteria. PPSV23 against 23 different types (serotypes) of Streptococcus pneumoniae bacteria. The CDC recommends this vaccine for adults 65 or older and those older than two years with certain medical conditions.
Pneumococcal Conjugate Vaccine (PCV15, PCV20, PCV21)
A conjugate vaccine is made by joining a protein to a string of polysaccharides to elicit a stronger immune response than the polysaccharide vaccine. PCVs protect against 15, 20, and 21 different serotypes of Streptococcus pneumoniae bacteria, respectively. The CDC recommends one of these vaccines for most eligible individuals.
Why is the Vaccine Important?
The pneumococcal shot reduces the rate of invasive pneumococcal disease. Data on the efficacy of PCV is based on earlier PCVs, including PCV7 and PCV13.
- Children who received PCV7 experienced a 20% reduction in X-ray-confirmed pneumonia episodes and a 7% decrease in middle ear infections.
- Getting PCV13 protected 80% of children from invasive pneumococcal disease, 75% of adults 65 or older from invasive pneumococcal disease, and 45% of adults 65 or older from pneumococcal pneumonia.
- In children, the introduction of PCVs has led to a decrease in pneumonia-related deaths by up to 35% in areas like Latin America, the Caribbean, and South Africa.
The PPSV23 is 60-70% effective in preventing invasive pneumococcal diseases caused by the serotypes covered in the vaccine.
For older adults, the PPV23 and PCV13 have been shown to reduce pneumonia hospitalizations by 60% and pneumococcal-related deaths by more than 90% in some studies.
Eligibility and Timing
The CDC recommends the pneumococcal vaccine for the following groups:
- Infants and Children: All children younger than 5 years should receive four doses of a pneumococcal conjugate vaccine (PCV15 or PCV20). The doses are typically administered at 2 months, 4 months, 6 months, and 12-15 months.
- Adults 50 and Older: One dose of PCV15, PCV20, or PCV21 is recommended for all adults 50 years or older who have never received any PCVs or whose previous vaccination history is unknown. If PCV15 is given, one dose of PPSV23 should be given one year later.
- High-Risk: Any child older than two or adult at an increased risk for pneumococcal disease may receive a single dose of PPSV23.
Addressing Common Concerns and Myths
It's normal to have questions about vaccine safety and efficacy. Let's address some common concerns and myths about the pneumococcal vaccine.
Are Pneumonia Vaccines Safe?
Pneumonia vaccines are safe. Allergic reactions can happen but are rare. The most common side effects associated with the PCV and PPSV are mild and resolve within two days. These could include:
- Redness, swelling, pain, and tenderness at the site of administration
- Fever or chills
- Loss of appetite
- Irritability in young children
- Fatigue
- Headache
- Muscle and joint aches
There is a small increased risk of febrile seizures (seizures caused by fever) in young children ages 6 months to 2 years within 24 hours of receiving the PCV13 vaccine at the same time as the inactivated influenza (flu) vaccine. To minimize the likelihood of febrile seizures, it is recommended that these two vaccines be administered on separate days.
Dispelling Common Myths
Myth: Only Adults Older Than 65 Need the Vaccine
Fact: Anyone can get pneumococcal disease. In addition to adults 65 years and older, high-risk groups include smokers, those with certain health conditions, and children under 5.
Myth: The Pneumonia Shot Can Make Me Sick
Fact: Pneumococcal vaccines are composed of inactivated bacterial components and do not contain live bacteria. Therefore, they cannot cause pneumococcal disease.
Myth: If I've Already Had Pneumonia, I Don't Need the Vaccine
Fact: Even if you've had pneumonia before, getting vaccinated can help protect you from different strains of the bacteria that cause pneumonia. There are more than 100 subtypes of Streptococcus pneumoniae. Having been sick with one type doesn't make you immune to others. The vaccine can provide broader protection and reduce the risk of future infections.
Myth: The Pneumonia Vaccine Provides Lifetime Protection
Fact: The protection offered by pneumonia vaccines can decrease over time. For example, the antibodies generated by the PPSV23 vaccine typically last about five years in healthy adults but may decline more quickly in people with chronic health conditions. Therefore, booster shots may be recommended to maintain protection, especially for those at higher risk.
Where and How to Get the Pneumonia Vaccine
Thinking of getting vaccinated but not sure how? These tips will help you determine where to receive the pneumonia vaccine, what to expect during the vaccination process, and how to handle the costs involved.
Where Can You Get Vaccinated?
Because the pneumococcal vaccine is part of the routine childhood immunization schedule, most children will receive their shots from their pediatrician at their family practice doctor's office.
Adults eligible for the vaccine should talk to their primary care physician or pharmacist. For those who don't have regular access to health care, federally funded health centers and community health clinics may provide vaccination services. Contact your local health department to learn more about vaccination sites in your area.
What to Expect During Vaccination
Getting vaccinated is a straightforward process. Here's what you can typically expect:
- When you arrive for your vaccination, a healthcare provider will ask about your medical history and any concerns you might have.
- The vaccine is given as an injection in the arm or thigh. The healthcare provider administering the shot will clean the area, give the shot, and then cover it with a bandage.
- After receiving the vaccine, you might be asked to wait for a short period, usually about 15 minutes, to make sure you don't have any immediate reactions.
- After getting vaccinated, you can go about your day as usual. Contact your healthcare provider if you experience any unusual symptoms.
Costs and Insurance Coverage
Medicaid, Medicare, and most private insurance companies typically cover the cost of the vaccine for those who are eligible. To find out if your insurance covers the pneumonia vaccine, you can review your insurance plan details or contact your insurance provider directly.
For those without insurance, options are available to receive the vaccine at low or no cost, especially for children. Programs like Vaccines for Children (VFC) provide free vaccines to children whose parents cannot afford them.
The Broader Impact of Vaccination
Pneumococcal vaccination has had a significant impact on public health globally. The introduction of PCVs has led to substantial reductions in pneumococcal disease incidence. For instance, PCV13 vaccination was estimated to have prevented 175.2 million cases of all pneumococcal diseases and 624,904 deaths globally between 2010 and 2019.
The reduction in pneumococcal disease is evident across various age groups. For example, the PSERENADE Project found that by six years after the introduction of PCV10 or PCV13, invasive pneumococcal disease due to vaccine-type serotypes declined by 83-99% in children under five years and by 54-96% in adults aged 65 years and older.
Role in Global Health Initiatives
The global vaccination rates have increased significantly due to recommendations from the World Health Organization (WHO) and funding from the GAVI Alliance, which have facilitated the introduction of PCVs into national immunization programs, especially in lower-income countries. As of 2012, 86 WHO member states had added PCV to their routine infant immunization schedules.
Community Protection (Herd Immunity)
Pneumococcal vaccination also contributes to herd immunity. Vaccinated children have reduced nasopharyngeal carriage of vaccine-type pneumococci, thereby decreasing transmission to unvaccinated individuals, including older children and adults. This indirect protection has been significant, with studies showing marked reductions in invasive pneumococcal disease among unvaccinated populations.
[signup]
Key Takeaways
- Pneumococcal disease poses a significant threat to public health. It includes serious illnesses like pneumonia, meningitis, and bloodstream infections, which can lead to hospitalization and even death, especially in high-risk populations.
- Fortunately, the pneumococcal vaccines (PCV and PPSV) have been shown to be effective in reducing both the incidence and severity of pneumococcal disease.
- The CDC recommends that children and adults receive pneumococcal vaccines according to specific guidelines. Children under five should follow a vaccination schedule that includes multiple doses of PCV, while adults over 50 and those with certain health conditions should receive either PCV or PPSV to ensure they are adequately protected.
- Vaccines are available at various locations and are covered under most insurance plans, making it accessible to stay up-to-date on vaccinations.
- Speak with your healthcare provider to determine if it’s time for you or your family members to receive the pneumococcal vaccine. Your healthcare provider can help you decide which type of vaccine is best for your specific needs and guide you on the optimal timing for vaccination.
%201.svg){kind=logo}
